Social responsibility is an integral part of DyonMed’s identity. From the very beginning, we have believed that our mission is not limited to the development and distribution of innovative products, but also includes contributing to public health through prevention and support initiatives.

We have implemented prevention and population screening programs in collaboration with scientific institutions, hospitals, and private healthcare professionals, aimed at early diagnosis and the prevention of serious diseases. These programs have focused on critical areas such as colorectal cancer, upper gastrointestinal cancer, early diagnosis of celiac disease in children, prostate cancer prevention, and differential diagnosis of gastrointestinal conditions such as Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD).

Within this framework, the innovative Colon Test by DyonMed -a Point of Care product that provides valuable indications for the early diagnosis of colorectal cancer- was incorporated into the national prevention program “PROLAMBANO” of the Ministry of Health, now serving as an officially recognized public health tool for prevention and early diagnosis, with its reliability and practicality acknowledged by the state.

At the same time, we actively support remote rural practices and health centers in islands and villages by providing access to reliable Point of Care products that deliver answers in just 5 minutes. In doing so, we substantially improve the quality of life of thousands of citizens who would otherwise face limited access to fast diagnosis.

Through our consulting partner, Alfa Consultancy, we design, organize, and implement prevention and screening programs in cooperation with public and private organizations. Additionally, we provide special pricing to support such initiatives, ensuring their feasibility on a wider scale. Our contribution to prevention is a tangible reflection of our commitment to serve not only healthcare professionals and patients, but society as a whole.